HeartLung.AI
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2450 Holcombe Blvd, Houston, Texas, 7702...Phone Number
(310) 510-6004Website
www.heartlung.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About HeartLung.AI
Focusing on preventing heart attack and lung cancer with supervised AI, mobile app, and noninvasive imaging. HeartLung received FDA Breakthrough Designation for AI-CAC that detects signs of heart disease in CT scans more accurately than humans.Explore more
HeartLung.AI Org Chart
MM
Research Associate & Fellow
HZ
Research Fellow
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HeartLung.AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once HeartLung.AI has new funding data
Product Launch: Get notified when HeartLung.AI launches new products
HeartLung.AI, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if HeartLung.AI had a recent Job posting/layoffs
Earning: See what the market has to say on HeartLung.AI recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if HeartLung.AI has recently received funding, and reach out quickly before it becomes old news!
Check out if HeartLung.AI is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at HeartLung.AI
Recommended Actions
Find VP level buyers at HeartLung.AI
Find more new buyers
Compare Similar Companies to HeartLung.AI
Compare insights from companies similar to HeartLung.AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
HeartLung.AI is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
HeartLung.AI is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about HeartLung.AI.
HeartLung.AI Tech Stack
A closer look at the technologies used by HeartLung.AI
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
HeartLung.AI News & Media
RSNA Features HeartLung.AI Study Linking AI-Quantified Myosteatosis to Future COPD Risk
20-year MESA analysis finds CT-derived muscle quality predicts COPD more strongly than emphysema-like lung measures HOUSTON, TX, UNITED STATES, August 7, 2026 /EINPresswire.com/ -- HeartLung.AI today announced that the Radiological Society of North …Two HeartLung.AI Studies Show Routine Chest CT Assesses Cardiac Risk Like Dedicated Cardiac CT and Echocardiography
Complementary MESA analyses validate AI-derived chamber volumetry from non-gated, non-contrast CT for heart failure and atrial fibrillation risk assessment HOUSTON, TX, UNITED STATES, July 16, 2026 /EINPresswire.com/ -- HeartLung.AI announced the …HeartLung Launches 'Why Pay More and Get Less?' Campaign at SCCT 2026
AI-CVD challenges plaque-centric AI-CCTA with CAC-based primary prevention: one non-contrast CT, lower cost and radiation, 10+ reports. SAN DIEGO, CA, UNITED STATES, July 6, 2026 /EINPresswire.com/ -- HeartLung Corporation (HeartLung.AI), a medical AI …AHA Stroke Alert Podcast Features HeartLung.AI Research on AI-Predicted Atrial Fibrillation and Stroke
AI-derived left atrial volume and chamber ratios from CAC scans predicted long-term AF and stroke in MESA and Framingham. HOUSTON, TX, UNITED STATES, June 19, 2026 /EINPresswire.com/ -- HeartLung.AI today announced that its research article, "AI- …
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding HeartLung.AI
Sign Up For FreeTo access detailed company insights
Focusing on preventing heart attack and lung cancer with supervised AI, mobile app, and noninvasive imaging. HeartLung received FDA Breakthrough Designation for AI-CAC that detects signs of heart disease in CT scans more accurately than humans.... Read More
